Espervita
3 known investors
Espervita Therapeutics develops metabolic reprogramming therapies targeting liver and kidney disease, with a lead program in acetyl-CoA metabolic enzyme inhibitors. The company focuses on treating progressive metabolic liver diseases and related conditions.
Founders & leadership
RN
Roger NewtonFounder / Board Advisor
JL
James LallyFounder / Board Advisor
Investors · 3
Frequently asked questions
- What does Espervita do?
- Espervita Therapeutics develops metabolic reprogramming therapies targeting liver and kidney disease, with a lead program in acetyl-CoA metabolic enzyme inhibitors. The company focuses on treating progressive metabolic liver diseases and related conditions.
- Who founded Espervita?
- Espervita was founded by Roger Newton, James Lally.
- Who are Espervita's investors?
- Espervita's investors include ID Ventures, Michigan Rise, WMU Biosciences Research & Commercialization Center.